These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 11748435)
21. [Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer]. Liu ZZ; Lu ZD; Zhang HW; Yang H; Liu H; Li LF; Li WL; Cui SD Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):544-6. PubMed ID: 22093636 [TBL] [Abstract][Full Text] [Related]
22. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression. Kao A; Shiun SC; Hsu NY; Sun SS; Lee CC; Lin CC Ann Oncol; 2001 Nov; 12(11):1561-6. PubMed ID: 11822755 [TBL] [Abstract][Full Text] [Related]
23. Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma. Wang H; Chen XP; Qiu FZ World J Gastroenterol; 2004 May; 10(9):1281-5. PubMed ID: 15112342 [TBL] [Abstract][Full Text] [Related]
24. Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIBI uptake in breast cancer. Kostakoglu L; Ruacan S; Ergün EL; Sayek I; Elahi N; Bekdik CF J Nucl Med; 1998 Jun; 39(6):1021-6. PubMed ID: 9627337 [TBL] [Abstract][Full Text] [Related]
25. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors. Kostakoglu L; Elahi N; Kïratlï P; Ruacan S; Sayek I; Baltalï E; Sungur A; Hayran M; Bekdik CF J Nucl Med; 1997 Jul; 38(7):1003-8. PubMed ID: 9225779 [TBL] [Abstract][Full Text] [Related]
26. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities. Moustafa H; Riad R; Omar W; Zaher A; Ebied E Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955 [TBL] [Abstract][Full Text] [Related]
27. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI. Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of 99mTc MIBI scintimammography in patients with breast lesions. Yildiz A; Colak T; Güngör F; Ozuğur S; Boz A; Tunçdemir F; Akaydin M Rev Esp Med Nucl; 2001 Jun; 20(4):276-81. PubMed ID: 11440709 [TBL] [Abstract][Full Text] [Related]
29. Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptake. Marshall C; Eremin J; El-Sheemy M; Eremin O; Griffiths PA Nucl Med Commun; 2005 Jan; 26(1):9-15. PubMed ID: 15604942 [TBL] [Abstract][Full Text] [Related]
30. Different methods for the detection of small changes in uptake between single-photon emission computed tomography (SPECT) examinations: 99mTc-sestamibi in chemotherapy for breast tumours. Jacobsson H; Wilczek B; Bergh J; von Schoultz E; Eriksson E; Larsson SA Nucl Med Commun; 2006 Apr; 27(4):347-52. PubMed ID: 16531920 [TBL] [Abstract][Full Text] [Related]
31. Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival. Dunnwald LK; Gralow JR; Ellis GK; Livingston RB; Linden HM; Lawton TJ; Barlow WE; Schubert EK; Mankoff DA Cancer; 2005 Feb; 103(4):680-8. PubMed ID: 15637688 [TBL] [Abstract][Full Text] [Related]
32. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer. Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086 [TBL] [Abstract][Full Text] [Related]
33. Uptake of Tc-99m MIBI related to tumour size and type. Buscombe JR; Cwikla JB; Thakrar DS; Hilson AJ Anticancer Res; 1997; 17(3B):1693-4. PubMed ID: 9179220 [TBL] [Abstract][Full Text] [Related]
34. P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings. Kao CH; Tsai SC; Liu TJ; Ho YJ; Wang JJ; Ho ST; ChangLai SP Cancer Res; 2001 Feb; 61(4):1412-4. PubMed ID: 11245443 [TBL] [Abstract][Full Text] [Related]
35. 99mTc-MIBI scintigraphy as an indicator of the chemosensitivity of anthracyclines in patients with breast cancer. Fujii H; Nakamura K; Kubo A; Enomoto K; Ikeda T; Kubota T; Matsuzaki SW; Kitajima M Anticancer Res; 1998; 18(6B):4601-5. PubMed ID: 9891525 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic Value of Semiquantitative Analysis of 99mTechnetium-Methoxyisobutylisonitrile (99mTc-MIBI) Imaging in Predicting Early-Stage Cervical Lymph Node Metastasis of Thyroid Carcinoma. Zhu XC; Zhou K; Xu SQ; Ma YB Med Sci Monit; 2017 Mar; 23():1552-1558. PubMed ID: 28362720 [TBL] [Abstract][Full Text] [Related]
37. Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma. Kim YS; Cho SW; Lee KJ; Hahm KB; Wang HJ; Yim H; Jin YM; Park CH Clin Nucl Med; 1999 Nov; 24(11):874-9. PubMed ID: 10551471 [TBL] [Abstract][Full Text] [Related]
38. Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma. Pace L; Catalano L; Del Vecchio S; De Renzo A; Fonti R; Salvatore B; Andretta C; Di Nuzzo C; Rotoli B; Salvatore M Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):281-5. PubMed ID: 16172574 [TBL] [Abstract][Full Text] [Related]
39. Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression, encoded by the multidrug resistance gene-1 messenger ribonucleic acid, in intracranial meningiomas. Kunishio K; Morisaki K; Matsumoto Y; Nagao S; Nishiyama Y Neurol Med Chir (Tokyo); 2003 Dec; 43(12):573-80; discussion 581. PubMed ID: 14723263 [TBL] [Abstract][Full Text] [Related]
40. Semi-quantitative assessment of 99Tcm-sestamibi uptake in lung cancer: relationship with clinical response to chemotherapy. Ceriani L; Giovanella L; Bandera M; Beghe B; Ortelli M; Roncari G Nucl Med Commun; 1997 Nov; 18(11):1087-97. PubMed ID: 9423210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]